medRxiv preprint doi: https://doi.org/10.1101/2020.03.10.20033670; this version posted March 13, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
All rights reserved. No reuse allowed without permission.

The Prediction for Development of COVID-19 in Global Major Epidemic Areas Through Empirical Trends
in China by Utilizing State Transition Matrix Model
Zhong Zheng1â€ ; Ke Wu, MD12â€ ; Zhixian Yao1â€ ; Junhua Zheng, MD12*; Jian Chen, MD345*
1.
Department of Urology, Shanghai General Hospital, Shanghai Jiao Tong University, School of Medicine,
Shanghai, China. (Z. Zhong, K. Wu, Z. Yao, J. Zheng)
2.
Department of Evidence-based medicine, Shanghai General Hospital, Shanghai Jiao Tong University,
School of Medicine, Shanghai, China. (K. Wu, J. Zheng)
3.

CreditWise Technology Company Limited, Chengdu, China. (J. Chen)

4.

Caixin Insight Group, Beijing, China. (J. Chen)

5.

MSCI, Shanghai, China. (J. Chen)

*Correspondence:
Jian Chen
CreditWise Technology Co., Ltd. Floor 4-5, Section B, Building 1 Tianfu 5th Ave., Chengdu Hi-tech Zone Chengdu,
610041, China.
E-mail: jian.chen@jhu.edu.
TEL: 18717887110.

Junhua Zheng
Department of Evidence-based medicine, Shanghai General Hospital, Shanghai Jiao Tong University, School of
Medicine, Haining Road 100, 200080 , China.
E-mail: zhengjh0471@sina.com.
TEL: 13901722408.

â€ Zhong Zheng, Ke Wu, and Zhixian Yao contributed equally to this work

1
NOTE: This preprint reports new research that has not been certified by peer review and should not be used to guide clinical practice.

medRxiv preprint doi: https://doi.org/10.1101/2020.03.10.20033670; this version posted March 13, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
All rights reserved. No reuse allowed without permission.

Abstract
Background: Since pneumonia caused by coronavirus disease 2019 (COVID-19) broke out in Wuhan, Hubei
province, China, tremendous infected cases has risen all over the world attributed to high transmissibility. We
managed to mathematically forecast the inflection point (IFP) of new cases in South Korea, Italy, and Iran, utilizing
the transcendental model from Hubei and non-Hubei in China.
Methods: We extracted data from reports released by the National Health Commission of the Peopleâ€™s Republic of
China (Dec 31, 2019 to Mar 5, 2020) and the World Health Organization (Jan 20, 2020 to Mar 5, 2020) as the
training set to deduce the arrival of the IFP of new cases in Hubei and non-Hubei on subsequent days and the data
from Mar 6 to Mar 9 as validation set. New close contacts, newly confirmed cases, cumulative confirmed cases,
non-severe cases, severe cases, critical cases, cured cases, and death data were collected and analyzed. Using this
state transition matrix model, the horizon of the IFP of time (the rate of new increment reaches zero) could be
predicted in South Korean, Italy, and Iran. Also, through this model, the global trend of the epidemic will be
decoded to allocate international medical resources better and instruct the strategy for quarantine.
Results: the optimistic scenario (non-Hubei model, daily increment rate of -3.87%), the relative pessimistic scenario
(Hubei model, daily increment rate of -2.20%), and the relatively pessimistic scenario (adjustment, daily increment
rate of -1.50%) were inferred and modeling from data in China. Matching and fitting with these scenarios, the IFP of
time in South Korea would be Mar 6-Mar 12, Italy Mar 10-Mar 24, and Iran is Mar 10-Mar 24. The numbers of
cumulative confirmed patients will reach approximately 20k in South Korea, 209k in Italy, and 226k in Iran under
fitting scenarios, respectively. There should be room for improvement if these metrics continue to improve. In that
case, the IFP will arrive earlier than our estimation. However, with the adoption of different diagnosis criteria, the
variation of new cases could impose various influences in the predictive model. If that happens, the IFP of increment
will be higher than predicted above.
Conclusion: We can affirm that the end of the burst of the epidemic is still inapproachable, and the number of
confirmed cases is still escalating. With the augment of data, the world epidemic trend could be further predicted,
and it is imperative to consummate the assignment of global medical resources to manipulate the development of
COVID-19.

Keywords: coronavirus disease 2019; acute respiratory disease; prediction; inflection point; the state transition
matrix model

Introduction
Since the first case of novel coronavirus pneumonia (NCP), caused by coronavirus disease 2019 (COVID-19),
occurred in Wuhan, Hubei Province, China, the dreadful epidemic broke out during Dec 2019-Mar 2020 under the
pace of Chinese Spring Festival [1]. With the untiring efforts of the people and the selfless dedication of medical
staff, a total of 59,897 cured patients were discharged [2]. As of 24:00 on Mar 9, China has accumulated a total of
80,754 confirmed cases (including 4,794 severe cases) and 3136 dead cases [3]. However, in January, when the
large-scale outbreak in China began, the disease initiated to spread to other parts of the world [4, 5]. As of Mar 9, a
total of 7,382 cases were confirmed in South Korea, 7,375 cases in Italy, and 6,566 cases in Iran [6].
Similar to another coronavirus (CoV) â€”SARS-CoVâ€” COVID-19 is an RNA virus that contains particular spike
proteins conjugating with angiotensin-converting enzyme 2 (ACE2) that widely expressed in different tissues [7].
However, its doughty transmissibility in the community has a strong correlation with reasons such as long
incubation period, mild early symptoms, and the like [8, 9]. Even though some studies have proved that Remdesivir
designed for the Ebola virus may have a promising effect on COVID-19 [10], the kernel strategies for the prevention
and treatment of NCP are still effective quarantine as in the case of SARS [11]. After the implementation of strict
isolation, the most significant thing is the arrival of the peak and inflection point (IFP) of new cases of NCP for
assessing the efficacy of current strategies.

2

medRxiv preprint doi: https://doi.org/10.1101/2020.03.10.20033670; this version posted March 13, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
All rights reserved. No reuse allowed without permission.

Based on the previous data, we analyzed the epidemic situation in Hubei Province [12]. After the validation of the
model, we were able to analyze the world epidemic trends, and predict the arrival of peaks and IFPs of newly
confirmed cases and provide references for NCP prevention and control strategies in various countries.

Method
Study Population, Data Collection, and analysis
Data from reports, including medical observation, close contacts, confirmed cases, severe cases, critical cases,
cured cases and death data and corresponding information, released by the Health Commission of Hubei Province
(HCHP) (Dec 31, 2019 to Feb 8, 2020) were extracted as the training set. Primarily, the arrival of the IFP of new
cases and epidemic trends in Hubei were deduced and testified in the validation set, whose data were extracted from
HCHP (Feb 9, 2020 to Mar 5, 2020). Subsequently, another training set consisting of the data from the National
Health Commission of the Peopleâ€™s Republic of China (NHC) and the World Health Organization (WHO) (Jan 20,
2020 to Mar 5, 2020) were established. Eventually, the data, including cumulative confirmed cases, cumulative
cured cases, death data and corresponding information, from NHC and WHO (Mar 6, 2020 to Mar 9 2020) were
collected and constructed the validation set. The data period starts from Dec 31, 2019 to Mar 9, 2020. Data is
updated on the daily basis. All data were analyzed using Microsoft Excel (Microsoft Office 2016) and R studio (R
Foundation for Statistical Computing, Vienna, Austria). The world epidemic situation was performed using the
nCov2019 package of R [13]. Histogram was obtained using the ggplot2 packages of R.

State Transition Matrix Model
State transition matrix (STM) modeling is a well-regarded approach widely applied in clinical decision analysis
based on computer simulation. For estimating the IFP of newly confirmed cases and the scale of cumulative cases in
the globe in subsequent days, we chose the Markov model cohort simulation.

Parameter Selection and Estimate
In order to estimate the risk metrics (infectivity, severity, lethality) of the NCP, we build a STM model as
showing in the figure (Figure.1).
We define the states in this model. Medical Observation (MO) is the close contact of confirmed cases and put into
medical observation. In the subsequent days, outcome could be any of the three: confirmed cases, discharged
without COVID-19 infection, or stay in MO. Discharge (Disc) is a terminal state for a close contact, until he or she
becomes another incident of close contact again. Infected is an intermediate state, where the patient becomes a
confirmed infected case. The outcome is binary: severe, or non-severe. And the outcome is revealed immediately.
Non-Severe Case (NS) is the patient also has three possible outcomes in the next day: cure, severe case, or stay in
non-severe case. Severe Case (S), the patient has three possible outcomes in the next day: critical case, non-severe
case, or stay in severe case. Critical Case (Cr), the patient has three possible outcomes in the next day: cured case,
severe case, or stay in critical case. Cured Case (Cu) and Death (D) are also the terminal states for the patient. So, at
any moment, we can identify the close contact or patientâ€™s state by utilizing a state vector, defined as the following:

V   



 ]â€™

Where each element of the vector stands for one state in the same sequentially arranged order as mentioned above.
Please note that the comfirmed itself is not an independent state, since the outcome is revealed instantaneously, so
we combine confirmed case with Non-Severe, Severe, and Critical cases.
For each person, the state vector can only have one element with value of 1, and the other elements all have value
of zero. For example, if a patient is currently in state â€œSevere Caseâ€, the state vector for him is â€˜[0 0 0 1 0 0 0]â€™. The
next day, his state vector could become either â€˜[0 0 0 0 1 0 0]â€™ (Critical Case), â€˜[0 0 1 0 0 0 0]â€™ (Non-Severe Case) or
stay the same.
3

medRxiv preprint doi: https://doi.org/10.1101/2020.03.10.20033670; this version posted March 13, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
All rights reserved. No reuse allowed without permission.

For the sample population, the state vector is defined as the count of people in each state. For example, if there are
100 patients being treated today, out of which 10 are critical, and 90 are severe. The state vector for this sample
population is [0 0 0 90 10 0 0]â€™.
Letâ€™s define the STM as the following:

TransMatrix   , 
Where

 ,    !  "!## $!% &  ! & '
Suppose we have a state vector V(t) for a sample population at time t, how do we predict the state vector V(t+1)
in the next day?
Apply simple linear algebra, we can get the following equation:

V(t ) 1+  TransMatrix , V(t+
Since the head count of a certain state comes from itself, all other possible transitions into the state (e.g. S has two
possible income states, MO and C), minus the outcome states (C, and Cu).
If we want to predict for N period, the equation becomes the following:

V(t ) N+  TransMatrix , V(t+
If the population is limited and the transition matrix is stationary, the above formula will be sufficient in
predicting all future outcomes. In our case, the population is not fixed, so we need to introduce the additional input
into the population: new close contacts (NCC).
Every day, new close contacts are added to the medical observation pool, as people already in the pool will
gradually be discharged or confirmed of infection.

MO(t ) 1+  MO(t+ ) NCC(t ) 1+ 0 Disc(t ) 1+ 0 Con4irmed(t ) 1+
Also, we assume NCC will gradually decay as quarantine measures are put into effect.

NCC(t ) N+  e





, NCC(t+

Using this STM model, we will be able predict when the inflection peak time as well as IFP of newly confirmed
cases (the maximum open infection cases) in Hubei Province or non-Hubei will occur. Moreover, after verifying this
matrix model in China, it could be utilized to evaluate the world epidemic development especially in the major
epidemic areas.
Although there is an intermediate state during the above hospitalization: severe cases (the new standard is broken
down into mild and normal), critical cases (which can also be divided into general critical and critical), due to the
lack of intermediate state transfer probability, we combine the entire hospital period into a in-patient state, for the
sake of keeping the model simple. This minimizes the need for only the following five parameters.
Increment of New Close Contacts (NCC), defined as ln(NCC(t)/NCC(t-1));
Discharge Rate from Medical Observation (MO), defined as Discharged(t)/MO(t-1)
Transitional Probability of Medical Observation -> Confirmed cases, defined as Newly confirmed cases
(t)/MO(t-1)
Transitional Probability of Treatment -> Death, defined as New Death Incidents(t) / Treatment(t-1)
Transitional Probability of Treatment -> Cured, defined as New Cured Incidents (t) / Treatment(t-1)
In order to estimate the count of open non-severe cases, severe cases, and critical cases, we need three more
parameters:
Ratio of Non-Severe Cases
Ratio of Severe Cases
Ratio of Critical Cases
4

medRxiv preprint doi: https://doi.org/10.1101/2020.03.10.20033670; this version posted March 13, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
All rights reserved. No reuse allowed without permission.

Scenario Setup and Prediction
After validation of the STM model in Hubei Province, we set up three different scenarios derived from China for
matching and fitting the major epidemic areas comprising South Korea, Italy, and Iran, in order to control for model
error, including optimistic scenario, cautiously optimistic scenario, and relatively pessimistic scenario (Table.1).

Results
The status quo of Hubei Province, China, and the historical prediction model verification of Hubei Province.
According to the data of NHC[14], as of Mar 5, there were 67,592 cumulative confirmed cases, 41,966
cumulative cured cases, 126 newly confirmed cases, 29 new deaths, and 1,478 new cured cases, and 19,758 inpatient cases in Hubei Province (Figure.2A). The number of new close contacts in Hubei Province has gradually
decreased, and the cumulative number of close contacts is currently 271,959 (Figure.2B). The increment of new
close contacts has crossed the IFP (Figure.2C). Based on data from Dec 31, 2019 to Feb 8, 2020 in Hubei Province,
we built a prediction model through the STM model, and the cautiously optimistic scenario could consummately
predict the arrival of the IFP and several peak dates in Hubei (Table.2), which undoubtedly validate the predictive
efficacy of this mathematic model.

Epidemic situation in training set and the epidemic trend fitting model.
As of Mar 5, there were 23,784 confirmed cases, 53,726 cumulative cured cases, 3042 cumulative deaths, 80,552
cumulative confirmed cases, and 670,854 cumulative close contacts in China. Through the analysis, the 5-day
moving average (5DMA) and 10-day moving average (10DMA) increment of the confirmed case in Hubei and nonHubei suggested that the IFP in China was from Feb 6 to Feb 13 (Figure. 3A and B).
Applying the STM model again to establish a 10DMA increment of confirmed cases model in non-Hubei, the
fitting line of the trend in non-Hubei could be obtained, which is

  00.0387= ) 1696.2 (R2 = 0.883) (Figure.3C).
Similarly, in Hubei, the fitting line is

  00.022= ) 965.69 (R2 = 0.9096) (Figure.3D).
According to the derivatives taken from fitting lines, the epidemic trend in non-Hubei was set as an optimistic
scenario with increment of -3.87%, and the epidemic trend in Hubei as a cautiously optimistic scenario with
increment of -2.20%, and set a relatively pessimistic scenario with increment of -1.50% (Table.1), which could
forecast the situation outside China.

International epidemic situation and prediction.
Data from WHO shows that there were 2,232 new cases worldwide on Mar 5, the cumulative number of
confirmed cases reached 95,324, and a total of 85 countries have suffered this epidemic (Figure. 4A) [6]. Starting
from the cumulative 50 confirmed cases (T50), the cumulative confirmed case trends were compared in different
countries with China, and it showed that the trends of France, Germany, United Kingdom, the United States, and
Spain stayed steady, while the trends of newly confirmed cases in Korea, Italy, and Iran laid between Hubei and
non-Hubei, which have been identified as the major epidemic areas in the globe (Figure.4B and C).
Then the established STM model was implemented to the three countries. The results showed that the IFP in
South Korea would arrive from Mar 6 to Mar 12 (Figure. 5A and B); the IFP in Italy would arrive from Mar 10 to
Mar 24 (Figure. 5C and D); the IFP in Iran would come from Mar 10 to Mar 24 (Figure. 5E and F). After
completing the model and training set establishment, we compared the cumulative case prediction with the actual
5

medRxiv preprint doi: https://doi.org/10.1101/2020.03.10.20033670; this version posted March 13, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
All rights reserved. No reuse allowed without permission.

data on Mar 6 and Mar 9, which was validation set, and the results overtly testified the efficacy of this prediction
model all in Korean, Italy, and Iran (Table.3). By utilizing this model, the approximate number of confirmed cases
in the three countries at the end of March, April, and May could be predicted (details show in Figure.6), which could
instruct the international medical resources allocation.

Discussion
Given the punchy transmissibility of COVID-19 [15], isolation and quarantine are undoubtedly the primary
options [11]. Subsequently, the model of this epidemic sprouted out a lot. Ziff et al. established a model of death
cases and reported that death cases follow three patterns: exponential growth, power-law behavior, and then
exponential decline in the daily rate [16]. Nevertheless, deaths are affected by many factors, such as age [17, 18].
More attention should be paid to the number of new cases, and the rate of increment, attributed to the effect of
epidemic prevention and control, can be evaluated to guide the date of return to work.
Moreover, we must strictly follow the coping strategy and learn the Chinese model for dealing with NCP
outbreaks. Li et al. developed a simple regression model, and based on this model, they estimated that about 34
founder patients outside of China were not observed in the early stage of transmission, and the global trend
approximated an exponential increase, tenfold increase in 19 days [19]. This study reproduced the disease's initial
spread to the world, yet made no prediction for the future trend, and exponential growth will be curbed immediately
after the attention of local governments, and the IFP will come. Milan Batista proposed an estimate of the final size
of the COVID-19 epidemic, the logistic growth model and classic susceptible-infected-recovered dynamic model are
used to estimate the final size of the coronavirus epidemic, being approximately 83700 (Â±1300) cases and that the
peak of the epidemic was on Feb 9 2020 [20]. However, as of Mar 5, the number of global cases has reached 95,333,
and the IFP for growth in South Korea, Italy, and Iran has not yet arrived, which means the global size will be even
more colossal.
Our model is based on the fitting of real data from authorities. Through the STM Model, based on data from
Hubei and non-Hubei, we predict the IFPs in Korea, Italy, and Iran, while there are still some limitations. Due to the
large outbreaks started at different times all over the world, the effects of seasonal and geographical factors have not
been taken into account. Although the fitting with the Chinese model can better predict the situation around the
world, through reference and learning, the response strategies of other countries may be more mature. As China
resumes work, the production capacity of various medical resources will gear up rapidly, which will impose a
positive impact on the world, and it could be more optimistic that the IFP will come soon.
Local governments, regardless of the speed of outbreaks, should learn from China's primary response strategy,
such as stopping working, reducing gathering, preventing contact transmission, wearing masks, and implementing
quarantine. After the NCP being under control, the production and output of medical resources should be intensified,
the production of coronavirus detection kits should be accelerated, existing cases should be summarized. More
accurate diagnostic criteria should be compiled to prevent massive missed diagnoses in countries lacking the kit.
Even if it currently causes some global economic regression, the recovery will swiftly come after holding the throat
of NCP and COVID-19.

Conclusion
Based on data from China, we utilized the State Transition Matrix Model to predict the IFP of disease in countries
currently experiencing outbreaks worldwide. If properly controlled, the IFP in South Korea and Italy will come in
early March, and the IFP in Iran will come in mid-March. During this period, countries around the world should
work together to fight the epidemic.

Acknowledgements
Not applicable.
6

medRxiv preprint doi: https://doi.org/10.1101/2020.03.10.20033670; this version posted March 13, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
All rights reserved. No reuse allowed without permission.

Authors' contributions
Jian Chen and Junhua Zheng participated in study design; Zhong Zheng and Ke Wu performed data collection and
analysis; Zhixian Yao drafted the manuscript; all author provided critical review of the manuscript and approved the
final draft for publication.

Conflict of Interest
The authors declare no conflicts of interest.

Funding/Support
The reported work was supported in part by research grants from the Natural Science Foundation of China (no.
81972393, 81772705, 31570775).

Role of the Funder/Sponsor
The funders had no role in the design and conduct of the study; collection, management, analysis, and
interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript
for publication.

Reference
1.
2.

3.

4.
5.

6.

7.
8.
9.
10.
11.

Li, Q., et al., Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia.
N Engl J Med, 2020.
NHC, Update on the epidemic situation of new coronavirus pneumonia as of 24:00 on March 9. National
Health Commission of the People's Republic of China.
http://www.nhc.gov.cn/xcs/yqtb/202003/948a03ad76f54d3583a018785efd7be9.shtml (accessed 10 March
2020).
WHO, Novel coronavirus (2019-nCoV) situation report 49. World Health Organization, 2020.
https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200309-sitrep-49-covid19.pdf?sfvrsn=70dabe61_4(accessed (09 March 2020).
Holshue, M.L., et al., First Case of 2019 Novel Coronavirus in the United States. N Engl J Med, 2020.
382(10): p. 929-936.
WHO, Novel coronavirus (2019-nCoV) situation report 1. World Health Organization, 2020.
https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200121-sitrep-1-2019ncov.pdf?sfvrsn=20a99c10_4 (accessed 21 January 2020).
WHO, Novel coronavirus (2019-nCoV) situation report 45. World Health Organization, 2020.
https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200305-sitrep-45-covid19.pdf?sfvrsn=ed2ba78b_4 (accessed 05 March 2020).
Tian, X., et al., Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific
human monoclonal antibody. Emerg Microbes Infect, 2020. 9(1): p. 382-385.
Rothe, C., et al., Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany. N Engl
J Med, 2020. 382(10): p. 970-971.
Liu, J., et al., Community Transmission of Severe Acute Respiratory Syndrome Coronavirus 2, Shenzhen,
China, 2020. Emerg Infect Dis, 2020. 26(6).
Wang, M., et al., Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus
(2019-nCoV) in vitro. Cell Res, 2020. 30(3): p. 269-271.
Wilder-Smith, A. and D.O. Freedman, Isolation, quarantine, social distancing and community containment:
pivotal role for old-style public health measures in the novel coronavirus (2019-nCoV) outbreak. J Travel
Med, 2020.
7

medRxiv preprint doi: https://doi.org/10.1101/2020.03.10.20033670; this version posted March 13, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
All rights reserved. No reuse allowed without permission.

12.
13.
14.

15.
16.
17.

18.
19.
20.

Wu, K., J. Zheng, and J. Chen, Utilize State Transition Matrix Model to Predict the Novel Corona Virus
Infection Peak and Patient Distribution. medRxiv, 2020: p. 2020.02.16.20023614.
Wu, T., et al., Open-source analytics tools for studying the COVID-19 coronavirus outbreak. medRxiv,
2020: p. 2020.02.25.20027433.
NHC, Update on the epidemic situation of new coronavirus pneumonia as of 24:00 on March 5. National
Health Commission of the People's Republic of China.
http://www.nhc.gov.cn/yjb/s7860/202003/b59dbcc84ed1498292714975039dcdc9.shtml (accessed 06
March 2020).
Chen, T.M., et al., A mathematical model for simulating the phase-based transmissibility of a novel
coronavirus. Infect Dis Poverty, 2020. 9(1): p. 24.
Ziff, A.L. and R.M. Ziff, Fractal kinetics of COVID-19 pandemic. medRxiv, 2020: p.
2020.02.16.20023820.
Patel, A. and D.B. Jernigan, Initial Public Health Response and Interim Clinical Guidance for the 2019
Novel Coronavirus Outbreak - United States, December 31, 2019-February 4, 2020. MMWR Morb Mortal
Wkly Rep, 2020. 69(5): p. 140-146.
Wang, W., J. Tang, and F. Wei, Updated understanding of the outbreak of 2019 novel coronavirus (2019nCoV) in Wuhan, China. J Med Virol, 2020. 92(4): p. 441-447.
Li, Y., et al., COVID-19 Epidemic Outside China: 34 Founders and Exponential Growth. medRxiv, 2020:
p. 2020.03.01.20029819.
batista, m., Estimation of the final size of the COVID-19 epidemic. medRxiv, 2020: p.
2020.02.16.20023606.

8

medRxiv preprint doi: https://doi.org/10.1101/2020.03.10.20033670; this version posted March 13, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
All rights reserved. No reuse allowed without permission.

Table.1 Scenarios for the prediction of outside China.

Scenario

S1

S2

S3

Minimum
Inc
Daily
Inc

-30%

-20%

-5%

-3.87%

-2.20%

-1.50%

Table 1. S1: optimistic scenario; S2: cautiously optimistic scenario; S3: relatively pessimistic scenario; Inc:
increment.

9

medRxiv preprint doi: https://doi.org/10.1101/2020.03.10.20033670; this version posted March 13, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
All rights reserved. No reuse allowed without permission.

Table.2 Training set and Validation Set of the Epidemic Trend in Hubei Province.

Actual

Forecast

Key Metrics

S1

S2

S3

Inc of Confirmed Cases

-9.0%

-10%

-10%

-5%

-5%

-1%

-1%

MO Release Rate

16.0%

17.0%

10.50%

17.0%

10.50%

17.0%

10.50%

Peak of Active Cases

50,633

39,612

47,148

44,082

55,150

62,041

85,502

Peak Date

2020/2/16

2020/2/23

2020/2/28

2020/3/1

2020/3/7

2020/4/6

2020/4/14

Peak of Severe Cases

9,289

5,753

6,845

6,400

8,004

9,000

12,402

Peak Date

2020/2/16

2020/2/23

2020/2/28

2020/3/1

2020/3/7

2020/4/6

2020/4/14

Peak of Critical Cases

2,492

1,786

2,124

1,986

2,484

2,793

3,849

Peak Case

2020/2/21

2020/2/23

2020/2/28

2020/3/1

2020/3/7

2020/4/6

2020/4/14

Total Cases at Feb. End

66,907

54,189

64,064

60,192

71,596

68,045

81,284

Table 2. The actual data were extracted from HCHP, and the forecast data in the three scenarios were deduced by
the STM model based on the data before Feb 9, 2020. S1: optimistic scenario; S2: cautiously optimistic scenario; S3:
relatively pessimistic scenario; MO: medical observation; Inc: increment.

10

medRxiv preprint doi: https://doi.org/10.1101/2020.03.10.20033670; this version posted March 13, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
All rights reserved. No reuse allowed without permission.

Countries

South Korea
Actual

Date

Italy

Forecast

Actual

S1

S2

S3

Iran

Forecast

Actual

S1

S2

S3

Forecast
S1

S2

S3

2020/3/5

5,766

5,766

5,766

5,766

3,089

3,089

3,089

3,089

2,922

2,922

2,922

2,92

2020/3/6

6,284

6,199

6,221

6,239

3,858

3,794

3,844

3,852

3,513

3,613

3,678

3,68

2020/3/7

6,767

6,612

6,683

6,741

4,636

4,609

4,795

4,830

4,747

4,396

4,630

4,67

2020/3/8

7,134

6,990

7,142

7,268

5,883

5,515

5,965

6,064

5,823

5,250

5,806

5,92

2020/3/9

7,382

7,323

7,589

7,811

7,375

6,485

7,374

7,598

6,566

6,147

7,224

7,48

Table.3 Training Set and Validation Set of the Epidemic Trends in the Major Epidemic Areas.

Table 3. S1: optimistic scenario; S2: cautiously optimistic scenario; S3: relatively pessimistic scenario; Inc:
increment.

11

medRxiv preprint doi: https://doi.org/10.1101/2020.03.10.20033670; this version posted March 13, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
All rights reserved. No reuse allowed without permission.

Country

South Korean

Italy

Iran

Scenario

S1

S2

S3

S1

S2

S3

S1

S2

S3

2020/3/31

8,539

10,651

16,168

13,797

47,930

118,878

12,339

48,847

126,978

2020/4/30

8,541

10,695

19,454

13,815

49,797

192,593

12,353

50,795

208,006

2020/5/31

8,541

10,695

20,198

13,815

49,802

209,272

12,353

50,800

226,340

Table 4. Predictive Cumulative Confirmed Cases in the Major Epidemic Areas.

Table 4. S1: optimistic scenario; S2: cautiously optimistic scenario; S3: relatively pessimistic scenario.

12

medRxiv preprint doi: https://doi.org/10.1101/2020.03.10.20033670; this version posted March 13, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
All rights reserved. No reuse allowed without permission.

Figure 1. Process and outcome of the State Transition Matrix establishment when a Close Contact develops into the
state of Medical Observation.

Figure 2. A. The epidemic situation and general trend in Hubei Province, including new deaths, new cured cases,
newly confirmed cases, and in-patient number from Jan 15, 2020 to Mar 5, 2020. B. The trend of new close contacts
in Hubei Province from Jan 18, 2020 to Mar 5, 2020. C.The increment of new close contacts in Hubei Province
from Jan 18, 2020 to Mar 5, 2020. 3DMA: 3-day moving average; 5DMA: 5-day moving average.

Figure 3. AB. The increment of confirmed cases in Hubei and non-Hubei from Jan 22, 2020 to Mar 1, 2020. C. The
increment and fitting line of confirmed cases in non-Hubei. D. The increment and fitting line of confirmed cases in
Hubei. 5DMA: 5-day moving average; 10DMA: 10-day moving average.

Figure 4. A. Global distribution of confirmed cases with totally 95,324 cases on Mar 5, 2020. BC. Comparison of
the trends in non-major and major epidemic areas.

Figure 5. A to F. Predictive total confirmed cases and increment of confirmed cases in South Korean, Italy, and Iran,
respectively, with the three scenarios deduced by the State Transition Matrix Model based on the data before Mar 6,
2020.

Figure 6. Predictive cumulative confirmed cases in South Korean, Italy, and Iran, respectively, on Mar 31, Apr 30,
and May 31. See also Table.4.

13

